Non-invasive differentiation between aplastic anemia and myelodysplastic syndromes based on an 8-feature lightGBM model: A multicenter external validation study [0.03%]
基于轻量级梯度提升机模型的8个特征的非侵入性区别阵发性睡眠性血红蛋白尿与其他溶血性贫血的多中心外部验证研究
Sumei Wang,Zihan Cai,Wei Wei et al.
Sumei Wang et al.
Background: Given the highly overlapping pancytopenic phenotypes, non-invasive differentiation between aplastic anemia (AA) and myelodysplastic syndromes (MDS) remains a formidable clinical challenge. The current diagnost...
Non-culture based diagnostic tests for detection of bacterial infections in hematology patients with febrile neutropenia: A review by the European Conference on Infections in Leukemia (ECIL-10) [0.03%]
欧洲白血病感染大会（ECIL-10）对血液病患者非发热性中性粒细胞减少症细菌感染检测的非培养诊断试验的回顾性研究
Dionysios Neofytos,Patricia Muñoz,Dina Averbuch et al.
Dionysios Neofytos et al.
Background: Limited data are available on the performance of non-culture-based diagnostics in hematology patients with febrile neutropenia (FN). Methods: ...
Efficacy and safety of CD19 CAR T-cell therapy in relapsed/refractory follicular lymphoma: A systematic review and meta-analysis [0.03%]
CD19 CAR-T细胞治疗复发/难治性滤泡淋巴瘤疗效和安全性的系统评价和 Meta 分析
Leen Haj Saleh,Aly Adel Ata,Farah Alshaboul et al.
Leen Haj Saleh et al.
Background and aims: Follicular lymphoma (FL) is an indolent B-cell non-Hodgkin lymphoma characterized by frequent relapses despite initial responsiveness to chemoimmunotherapy. CD19-directed chimeric antigen receptor (CA...
Allogeneic mesenchymal stem cell therapy combined with photobiomodulation for neonatal soft-tissue necrosis: A case report [0.03%]
异体间充质干细胞治疗联合光生物调节治疗新生儿软组织坏死的病例报告
Thais de Andrade Farias Rodrigues,Edilene Villalba Dos Santos,Marina Juliana Pita Sassioto Silveira de Figueiredo et al.
Thais de Andrade Farias Rodrigues et al.
A 15-day-old neonate was admitted to a neonatal intensive care unit with peripheral ischemia and a right upper limb abscess following Bacillus Calmette-Guérin (BCG) vaccination. Laboratory findings revealed protein C and S deficiencies wit...
Detection of acute lymphocytic and myeloid leukaemia with optimized dimensionality reduction and deep learning classification framework [0.03%]
基于优化降维和深度学习分类框架的急性淋巴细胞白血病和髓系白血病检测模型研究
Mohamudha Parveen Rahamathulla,Shtwai Alsubai,Mohemmed Sha
Mohamudha Parveen Rahamathulla
Leukaemia is a deadly illness that affects a huge number of people all over the world. ALL (Acute lymphocytic Leukaemia) and AML (Acute Myelogenous Leukaemia) are the common type of leukaemia where AML widely affects older people and ALL co...
Comparison of genomic response among patients receiving dendritic cell vaccines pulsed with two different cancer-associated antigens: A retrospective observational study [0.03%]
两种不同癌症相关抗原脉冲树突细胞疫苗接种患者的基因组反应比较：回顾性观察研究
Khin Zay Yar Myint,Masamori Shimabuku,Yoko Shimizu et al.
Khin Zay Yar Myint et al.
Background: The evaluative and prognostic value of liquid biopsy in dendritic cell immunotherapy has not yet been studied, especially with respect to the use of the Wilms tumor gene 1 (WT1) peptide and tumor-specific anti...
A survey on artificial intelligence use for myeloma and lymphoma management [0.03%]
关于人工智能在多发性骨髓瘤和淋巴瘤管理中应用的调查研究
Halima Mokeddem,Layth Sliman,Hachemi Nabil Dellys et al.
Halima Mokeddem et al.
Background: Hematological malignancies, particularly multiple myeloma (MM) and lymphomas, pose major clinical challenges due to their biological complexity and inter-patient heterogeneity. Although diagnostic and therapeu...
Efficacy of bispecific T-cell engagers after CAR T-cell therapy failure in aggressive large B-cell lymphoma [0.03%]
CAR-T细胞治疗失败后用于侵袭性大B细胞淋巴瘤的双特异性T细胞接合器的效果
Mohamed A Kharfan-Dabaja,Tea Reljic,Sarah Abdel-Razeq et al.
Mohamed A Kharfan-Dabaja et al.
No recognized standard of care exists at the present time for treatment for large B-cell non-Hodgkin lymphoma that relapses or progresses after chimeric antigen receptor T-cell (CAR T-cell) therapy. Bispecific T-cell engagers (BiTEs) have e...
Donor demographics and leukopak consistency: Yield and composition as operational benchmarks for cell-therapy starting materials [0.03%]
捐赠者的人口统计学特征与白细胞浓缩液的稳定性：作为细胞治疗起始材料的收得率和成分的运营基准
Irene Gómez-Gràcia,Daniel Gonnermann,Lisa Paschold et al.
Irene Gómez-Gràcia et al.
Introduction: The success of allogeneic cell therapies depends on high-quality starting material derived from healthy donors. However, variability in donor characteristics and collection procedures such as leukapheresis c...
A fault tree analysis of early treatment failure in Acute myeloid leukemia [0.03%]
急性髓系白血病早期治疗失败的故障树分析
Mobina Shrestha,Salina Dahal,Vishal Mandal
Mobina Shrestha
Risk assessment in AML is mainly based on cytogenetic and molecular classification. Even with these systems, induction failure and early death remain common, especially in older patients. In clinical practice, patients often do poorly when ...